Innovent Biologics, Inc. (IVBXF)
USD 4.8
(0.0%)
USD 4.8
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.62 Billion CNY | 12.14% |
| 2022 | 3.22 Billion CNY | 29.3% |
| 2021 | 2.49 Billion CNY | 106.94% |
| 2020 | 1.2 Billion CNY | 39.47% |
| 2019 | 865.08 Million CNY | 9.23% |
| 2018 | 792 Million CNY | 55.29% |
| 2017 | 510 Million CNY | 2.0% |
| 2016 | 500 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 3.45 Billion CNY | 0.79% |
| 2023 Q4 | 3.62 Billion CNY | 0.7% |
| 2023 FY | 3.62 Billion CNY | 12.14% |
| 2023 Q3 | 3.59 Billion CNY | 4.14% |
| 2023 Q1 | 3.42 Billion CNY | 6.09% |
| 2022 Q2 | 2.76 Billion CNY | 0.58% |
| 2022 Q4 | 3.22 Billion CNY | 0.82% |
| 2022 FY | 3.22 Billion CNY | 29.3% |
| 2022 Q1 | 2.75 Billion CNY | 10.14% |
| 2022 Q3 | 3.2 Billion CNY | 15.76% |
| 2021 Q1 | 1.84 Billion CNY | 52.6% |
| 2021 FY | 2.49 Billion CNY | 106.94% |
| 2021 Q4 | 2.49 Billion CNY | 0.9% |
| 2021 Q3 | 2.47 Billion CNY | 33.32% |
| 2021 Q2 | 1.85 Billion CNY | 0.81% |
| 2020 Q2 | 970.85 Million CNY | 1.62% |
| 2020 Q1 | 955.4 Million CNY | 10.44% |
| 2020 FY | 1.2 Billion CNY | 39.47% |
| 2020 Q3 | 1.19 Billion CNY | 22.61% |
| 2020 Q4 | 1.2 Billion CNY | 1.36% |
| 2019 Q2 | 823.68 Million CNY | 0.86% |
| 2019 Q3 | 849.53 Million CNY | 3.14% |
| 2019 Q1 | 816.61 Million CNY | 3.11% |
| 2019 FY | 865.08 Million CNY | 9.23% |
| 2019 Q4 | 865.08 Million CNY | 1.83% |
| 2018 Q2 | 697 Million CNY | -83.59% |
| 2018 FY | 792 Million CNY | 55.29% |
| 2018 Q4 | 792 Million CNY | 0.0% |
| 2018 Q3 | 792 Million CNY | 13.63% |
| 2018 Q1 | 4.24 Billion CNY | 732.77% |
| 2017 Q3 | 3.56 Billion CNY | 0.0% |
| 2017 FY | 510 Million CNY | 2.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | 510 Million CNY | -85.68% |
| 2016 FY | 500 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -250227.141% |
| CSL Limited | 12.18 Billion USD | 70.282% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -8687.052% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -87735.196% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -900867.528% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -8247.426% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -12062.838% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -381703.198% |
| Mesoblast Limited | 118.7 Million USD | -2950.14% |
| Marizyme, Inc. | 18.71 Million USD | -19243.022% |
| Genus plc | 233.1 Million USD | -1453.208% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -123451.182% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -269368.005% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -482637.2% |
| ContraFect Corporation | 2.88 Million USD | -125569.177% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -2672133.498% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 28.88 Million USD | -12434.766% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -63885.563% |
| MultiCell Technologies, Inc. | 202.58 USD | -1787209397.482% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -6197.777% |
| EV Biologics, Inc. | 1.49 Million USD | -242116.195% |
| Q BioMed Inc. | 4.1 Million USD | -87991.137% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -10837.824% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -294644.705% |
| Biomind Labs Inc. | 735.54 Thousand USD | -492126.005% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -27756.662% |
| Skye Bioscience, Inc. | 4.61 Million USD | -78346.811% |
| SQZ Biotechnologies Company | 27.47 Million USD | -13079.458% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -2558252.294% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -61567.067% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -155557.741% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -14077154.17% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -574516.912% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | -2010.542% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -407587.847% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -160215.244% |
| GB Sciences, Inc. | 1.75 Million USD | -205692.906% |
| Alpha Cognition Inc. | 1.22 Million USD | -296574.211% |
| argenx SE | 20 Million USD | -18002.645% |
| HST Global, Inc. | 98.31 Thousand USD | -3682330.659% |
| Halberd Corporation | 150 Thousand USD | -2413586.0% |
| Enzolytics Inc. | 996.33 Thousand USD | -363283.611% |
| Resverlogix Corp. | 6.49 Million USD | -55677.677% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -1416426.73% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -7846.727% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -5252.419% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -119539.805% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -51089.4% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -1006413.302% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -133562.827% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| ONE Bio Corp. | 19.71 Million USD | -18264.317% |
| Zenith Capital Corp. | 10.22 Thousand USD | -35408496.577% |
| Genscript Biotech Corporation | 417.73 Million USD | -766.697% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -1804606.006% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -150898.572% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -1578910.515% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -2435440.921% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -1455564.603% |
| Agentix Corp. | 50 Thousand USD | -7240958.0% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 891.22 Thousand USD | -406141.402% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -17710.552% |
| BioStem Technologies, Inc. | 4.71 Million USD | -76745.862% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -1447058.069% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | 33.6 Thousand USD | -10773360.096% |
| Cell Source, Inc. | 9.25 Million USD | -39023.2% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -478676.759% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -478676.759% |
| NovAccess Global Inc. | 2.19 Million USD | -164478.477% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -1585229.959% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -1715993.85% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -72557.616% |
| CytoDyn Inc. | 30.07 Million USD | -11937.934% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -1028906.642% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -46198.562% |
| SYBLEU INC | 477.5 Thousand USD | -758125.969% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -2955433.878% |
| Rebus Holdings, Inc. | 310 Thousand USD | -1167812.581% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -76358.572% |
| Mobile Lads Corp. | 484.28 Thousand USD | -747504.505% |
| International Stem Cell Corporation | 4.17 Million USD | -86556.989% |
| Bioxytran, Inc. | 1.92 Million USD | -187979.429% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -5800821.282% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -165910.775% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -43436.905% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -42072.732% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -232659.748% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -1350843.657% |
| Neutra Corp. | 54.15 Thousand USD | -6685270.042% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -197743.115% |
| PureTech Health plc | 25.51 Million USD | -14091.475% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -295640.247% |
| IXICO plc | 472.02 Thousand USD | -766923.853% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -23256.745% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -5714.896% |
| CSL Limited | 12.18 Billion USD | 70.282% |
| Cellectis S.A. | 92.77 Million USD | -3802.42% |